BIOL351 / BIOL 351 Module 9 (Latest Update 2026 / 2027) Pharmacology | Questions & Answers | Grade A | 100% Correct - Portage Learning

BIOL351 / BIOL 351 Module 9
(Latest Update )
Pharmacology | Questions &
Answers | Grade A | 100% Correct -
Portage Learning

Specialty Medication




Question:
what term describes the subclass of biologics that specifically or
nonspecifically enhance or reduce the immune response
Answer:
immunomodulating drugs




Question:
are made using recombinant DNA technology
Answer:
monoclonal antibodies

,Question:
classified as lymphokines
Answer:
interleukins




Question:
Bevacizumab (Avastin) works by
Answer:
binding to and inhibiting vascular endothelial growth factor




Question:
works by inhibiting T-cell activation
Answer:
abatacept




Question:
works by preventing the complete fusion of HIV to the host cell
Answer:
fusion inhibitors

,Question:
the pill that launched a radical change in the treatment of Hepatitis C
Answer:
Ledipasvir/sofosbuvir (Harvoni)




Question:
work by blocking the enzyme integrase
Answer:
integrase inhibitors




Question:
work by incorporating themselves into the DNA and inhibiting the reverse
transcriptase and synthesis of new viruses
Answer:
nucleoside analogue reverse transcriptase inhibitors (NRTI)




Question:
work by inhibiting protease, an enzyme essential for the final assembly of the
new virus
Answer:
protease inhibitors

, Question:
poten inhibitor of CYP 3A4 enzymes within the liver and is used to increases
the concentrations of paritaprevir
Answer:
ritonavir




Question:
work by directly binding to the enzyme reverse transcriptase found within
HIV
Answer:
non-nucleoside reverse transcriptase inhibitors (NNRTI)




Question:
common symptoms of RA
Answer:
pain, stiffness, and reduced ROM